Literature DB >> 24179167

Antifibrotic therapy: is an antioxidative regimen the answer?

Frank Strutz1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24179167      PMCID： PMC3871788          DOI： 10.1681/ASN.2013101034

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  14 in total

1.  Pirfenidone for diabetic nephropathy.

Authors:  Kumar Sharma; Joachim H Ix; Anna V Mathew; Monique Cho; Axel Pflueger; Stephen R Dunn; Barbara Francos; Shoba Sharma; Bonita Falkner; Tracy A McGowan; Michael Donohue; Satish Ramachandrarao; Ronghui Xu; Fernando C Fervenza; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

Review 2.  Oxidative stress, anti-oxidant therapies and chronic kidney disease.

Authors:  David M Small; Jeff S Coombes; Nigel Bennett; David W Johnson; Glenda C Gobe
Journal:  Nephrology (Carlton)       Date:  2012-05       Impact factor: 2.506

3.  Effect of tranilast in early-stage diabetic nephropathy.

Authors:  Jun Soma; Kozo Sato; Harutaka Saito; Yoshinori Tsuchiya
Journal:  Nephrol Dial Transplant       Date:  2006-07-04       Impact factor: 5.992

4.  Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?

Authors:  Peter Rossing
Journal:  Nat Rev Nephrol       Date:  2013-02-05       Impact factor: 28.314

5.  Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

Authors:  Pablo E Pergola; Philip Raskin; Robert D Toto; Colin J Meyer; J Warren Huff; Eric B Grossman; Melissa Krauth; Stacey Ruiz; Paul Audhya; Heidi Christ-Schmidt; Janet Wittes; David G Warnock
Journal:  N Engl J Med       Date:  2011-06-24       Impact factor: 91.245

Review 6.  Potential methods to prevent interstitial fibrosis in renal disease.

Authors:  F Strutz
Journal:  Expert Opin Investig Drugs       Date:  2001-11       Impact factor: 6.206

Review 7.  The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

Authors:  Brendan B McCormick; Amy Sydor; Ayub Akbari; Dean Fergusson; Steve Doucette; Greg Knoll
Journal:  Am J Kidney Dis       Date:  2008-04-22       Impact factor: 8.860

8.  Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis.

Authors:  Monique E Cho; David C Smith; Mary H Branton; Scott R Penzak; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

Review 9.  The Nrf2 pathway in the progression of renal disease.

Authors:  Carlamaria Zoja; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nephrol Dial Transplant       Date:  2013-06-11       Impact factor: 5.992

10.  Fibrosis in the kidney: is a problem shared a problem halved?

Authors:  Tim D Hewitson
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
View more
  2 in total

1.  Does the greater omentum ("policeman of the abdomen") possess therapeutic utility in CKD?

Authors:  Christof Westenfelder
Journal:  J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 10.121

Review 2.  Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.

Authors:  Wenshan Lv; George W Booz; Fan Fan; Yangang Wang; Richard J Roman
Journal:  Front Physiol       Date:  2018-02-16       Impact factor: 4.566
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.